Table 2. . Kaplan–Meier median overall survival time estimates with 95% confidence intervals with log rank p-values.
Variable | Class | Median OS in months (95% CI) | p-value |
---|---|---|---|
Age | <65 years | 136.3 (129.2–144.0) | <0.0001 |
≥65 years | 39.2 (38.0–40.6) | ||
Race | Other | 66.7 (61.5–72.8) | 0.0595 |
Caucasian | 73.5 (71.4–76.5) | ||
Sex | Female | 116.9 (110.2–125.7) | <0.0001 |
Male | 58.6 (56.9–60.7) | ||
Insurance status | Medicaid/other government | 49.3 (45.5–56.9) | <0.0001 |
Medicare | 39.2 (38.0–40.6) | ||
Not insured | 60.1 (52.2–67.9) | ||
Private insurance | 145.5 (139.1–NE) | ||
Positive nodes, n | One node | 109.9 (103.5–116.7) | <0.0001 |
Two–three nodes or positive aspiration | 55.3 (52.1–58.2) | ||
Four or more nodes or positive nodes documented but number unspecified | 23.0 (22.3–24.1) | ||
Immunotherapy | No | 60.2 (58.4–62.2) | <0.0001 |
Yes | 140.4 (132.4–NE) | ||
Charlson–Deyo score | 0 | 85.0 (81.4–88.2) | <0.0001 |
1 | 46.3 (44.1–49.5) | ||
2 or 3 | 27.5 (25.0–31.8) |
NE: No estimate; NR: Not reached; OS: Overall survival.